» Articles » PMID: 36479247

Genomic Profiling and Network-level Understanding Uncover the Potential Genes and the Pathways in Hepatocellular Carcinoma

Abstract

Data integration with phenotypes such as gene expression, pathways or function, and protein-protein interactions data has proven to be a highly promising technique for improving human complex diseases, particularly cancer patient outcome prediction. Hepatocellular carcinoma is one of the most prevalent cancers, and the most common cause is chronic HBV and HCV infection, which is linked to the majority of cases, and HBV and HCV play a role in multistep carcinogenesis progression. We examined the list of known hepatocellular carcinoma biomarkers with the publicly available expression profile dataset of hepatocellular carcinoma infected with HCV from day 1 to day 10 in this study. The study covers an overexpression pattern for the selected biomarkers in clinical hepatocellular carcinoma patients, a combined investigation of these biomarkers with the gathered temporal dataset, temporal expression profiling changes, and temporal pathway enrichment following HCV infection. Following a temporal analysis, it was discovered that the early stages of HCV infection tend to be more harmful in terms of expression shifting patterns, and that there is no significant change after that, followed by a set of genes that are consistently altered. PI3K, cAMP, TGF, TNF, Rap1, NF-kB, Apoptosis, Longevity regulating pathway, signaling pathways regulating pluripotency of stem cells, Cytokine-cytokine receptor interaction, p53 signaling, Wnt signaling, Toll-like receptor signaling, and Hippo signaling pathways are just a few of the most commonly enriched pathways. The majority of these pathways are well-known for their roles in the immune system, infection and inflammation, and human illnesses like cancer. We also find that ADCY8, MYC, PTK2, CTNNB1, TP53, RB1, PRKCA, TCF7L2, PAK1, ITPR2, CYP3A4, UGT1A6, GCK, and FGFR2/3 appear to be among the prominent genes based on the networks of genes and pathways based on the copy number alterations, mutations, and structural variants study.

Citing Articles

Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation.

Khan B, Qahwaji R, Alfaifi M, Athar T, Khan A, Mobashir M Sci Rep. 2024; 14(1):28794.

PMID: 39567714 PMC: 11579425. DOI: 10.1038/s41598-024-80455-6.


Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug.

Mohammed O, Youssef M, Hamad R, Abdel-Reheim M, Saleh L, Alamri M PLoS One. 2024; 19(10):e0312572.

PMID: 39480853 PMC: 11527275. DOI: 10.1371/journal.pone.0312572.


Characterization of the Rat Osteosarcoma Cell Line UMR-106 by Long-Read Technologies Identifies a Large Block of Amplified Genes Associated with Human Disease.

Scott A, Mohr D, Littrell W, Babu R, Kokosinski M, Stinnett V Genes (Basel). 2024; 15(10).

PMID: 39457378 PMC: 11507229. DOI: 10.3390/genes15101254.


Pharmacogenomics: A Genetic Approach to Drug Development and Therapy.

Qahwaji R, Ashankyty I, Sannan N, Hazzazi M, Basabrain A, Mobashir M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065790 PMC: 11279827. DOI: 10.3390/ph17070940.


CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.

Bunz M, Eisele M, Hu D, Ritter M, Kammerloher J, Lampl S Front Cell Infect Microbiol. 2024; 14:1338606.

PMID: 38357447 PMC: 10864554. DOI: 10.3389/fcimb.2024.1338606.


References
1.
Anwer S, Mobashir M, Fantoukh O, Khan B, Imtiyaz K, Naqvi I . Synthesis of Silver Nano Particles Using Myricetin and the In-Vitro Assessment of Anti-Colorectal Cancer Activity: In-Silico Integration. Int J Mol Sci. 2022; 23(19). PMC: 9570303. DOI: 10.3390/ijms231911024. View

2.
Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

3.
Hass H, Vogel U, Scheurlen M, Jobst J . Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma. Anticancer Res. 2016; 36(10):5087-5095. DOI: 10.21873/anticanres.11078. View

4.
Uhlen M, Bjorling E, Agaton C, Szigyarto C, Amini B, Andersen E . A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005; 4(12):1920-32. DOI: 10.1074/mcp.M500279-MCP200. View

5.
Biesecker L, Spinner N . A genomic view of mosaicism and human disease. Nat Rev Genet. 2013; 14(5):307-20. DOI: 10.1038/nrg3424. View